MorphoSys AG
Company Profile
Business description
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.
Contact
Semmelweisstrasse 7
Planegg BY 82152
DEUT: +49 89899270
E: investors@morphosys.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
464
Stocks News & Analysis
stocks
Going into earnings, Is Apple stock a buy, a sell, or fairly valued?
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,153.40 | 59.10 | 0.73% |
| CAC 40 | 7,517.68 | 90.66 | 1.22% |
| DAX 40 | 18,417.55 | 118.83 | 0.65% |
| Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
| FTSE 100 | 8,285.71 | 99.36 | 1.21% |
| HKSE | 17,021.31 | 16.34 | 0.10% |
| NASDAQ | 17,357.88 | 176.16 | 1.03% |
| Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
| NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
| S&P 500 | 5,459.10 | 59.88 | 1.11% |
| S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
| SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
| Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
| Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
| Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
| Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
| Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
| South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
| Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |